{
  "thread": {
    "uuid": "d4c9b204c1b9b283aa54366922d438b9e50feda7",
    "url": "https://www.thepharmaletter.com/article/mhra-brings-in-stem-cell-robot-to-help-develop-therapies",
    "site_full": "www.thepharmaletter.com",
    "site": "thepharmaletter.com",
    "site_section": "https://www.thepharmaletter.com",
    "site_categories": [
      "media"
    ],
    "section_title": "Authoritative Pharma and Biotech News - The Pharma Letter",
    "title": "UK's MHRA brings in stem cell robot to help develop therapies",
    "title_full": "UK's MHRA brings in stem cell robot to help develop therapies",
    "published": "2024-04-04T03:00:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 56036,
    "domain_rank_updated": "2024-04-02T13:08:13.000+03:00",
    "reach": null,
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "gplus": {
        "shares": 0
      },
      "pinterest": {
        "shares": 0
      },
      "linkedin": {
        "shares": 0
      },
      "stumbledupon": {
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "d4c9b204c1b9b283aa54366922d438b9e50feda7",
  "url": "https://www.thepharmaletter.com/article/mhra-brings-in-stem-cell-robot-to-help-develop-therapies",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "The Pharma Letter",
  "published": "2024-04-04T03:00:00.000+03:00",
  "title": "UK's MHRA brings in stem cell robot to help develop therapies",
  "text": "04-04-2024 A new robot that grows stem cells is being trialled by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Potentially able to bring safer and more cost-effective treatments to people with a wide range of diseases, the CellQualia Intelligent Cell Processing System is the only one in the world outside of Japan, where it was developed. The trial is part of a UK-based international research program, launched in 2021, and a partnership… This article is accessible to registered users, to continue reading please [register for free](/page/subscribe). A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please [login](/page/login). If your trial has come to an end, you can [subscribe here.](/page/subscribe) Free 7 day trial access • All the news that moves the needle in pharma and biotech. • Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. • Receive The Pharma Letter daily news bulletin, free forever. £820 or £77 per month • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. • Daily roundup of key events in pharma and biotech. • Monthly in-depth briefings on Boardroom appointments and M&A news. • Choose from a cost-effective annual package or a flexible monthly subscription. [login](https://www.thepharmaletter.com/page/subscribe). Chairman, Sanofi Aventis UK [AI](https://www.thepharmaletter.com/listing/news/ai?tagid%5B%5D=95224) [Biotechnology](https://www.thepharmaletter.com/listing/news/biotechnology?tagid%5B%5D=7082) [Cell and Gene Therapy](https://www.thepharmaletter.com/listing/news/cell-and-gene-therapy?tagid%5B%5D=34788) [Digital Pharma](https://www.thepharmaletter.com/listing/news/digital-pharma?tagid%5B%5D=62610) [Focus On](https://www.thepharmaletter.com/listing/news/focus-on?tagid%5B%5D=39347) [Medicines and Healthcare products Regulatory Agency (MHRA)](https://www.thepharmaletter.com/listing/news/medicines-and-healthcare-products-regulatory-agency-mhra?tagid%5B%5D=87472) [Production](https://www.thepharmaletter.com/listing/news/production?tagid%5B%5D=14) [Regenerative Medicine](https://www.thepharmaletter.com/listing/news/regenerative-medicine?tagid%5B%5D=46505) [SINFONIA TECHNOLOGY CO., LTD.](https://www.thepharmaletter.com/listing/news/sinfonia-technology-co-44-nbsp-ltd?tagid%5B%5D=104564) [The UK Stem Cell Bank](https://www.thepharmaletter.com/listing/news/the-uk-stem-cell-bank?tagid%5B%5D=104565) [UK](https://www.thepharmaletter.com/listing/news/uk?tagid%5B%5D=8304)",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "external_links": [],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [
      {
        "name": "mhra",
        "sentiment": "negative"
      },
      {
        "name": "regulatory agency",
        "sentiment": "none"
      }
    ],
    "locations": [
      {
        "name": "uk",
        "sentiment": "none"
      },
      {
        "name": "japan",
        "sentiment": "none"
      }
    ]
  },
  "rating": null,
  "crawled": "2024-04-05T02:34:39.679+03:00",
  "updated": "2024-04-05T02:34:39.679+03:00"
}